What is the most recent earnings date for FIXX stock?
HOMOLOGY MEDICINES INC (FIXX) last reported earnings on 3/13/2024.
NASDAQ:FIXX • US4380831077
Past quarterly earnings results for HOMOLOGY MEDICINES INC (FIXX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2023 | -0.28 | -0.31 | 8.50% | 53.33% | - | -100.00% | ||
| Q3 2023 | -0.57 | -0.43 | -33.05% | 3.39% | 510K | -100.00% | -100.00% | |
| Q2 2023 | -0.61 | -0.48 | -25.90% | -19.61% | 350K | 858.157K | -59.21% | -56.25% |
| Q1 2023 | -0.50 | -0.54 | 7.51% | -150.00% | 800K | 1.035M | -22.71% | - |
| Q4 2022 | -0.60 | -0.51 | -16.77% | -1.69% | 800K | 847.008K | -5.55% | - |
| Q3 2022 | -0.59 | -0.48 | -22.42% | -9.26% | 800K | 877.608K | -8.84% | -52.38% |
| Q2 2022 | -0.51 | -0.57 | 9.97% | 5.56% | 800K | 1.021M | -21.65% | -63.47% |
| Q1 2022 | -0.20 | -0.36 | 43.98% | -900.00% | 800K | 21.106M | -96.21% | -97.27% |
| Q4 2021 | -0.59 | -0.60 | 2.33% | 4.84% | 800K | 756.728K | 5.72% | -18.37% |
| Q3 2021 | -0.54 | -0.61 | 11.72% | 12.90% | 1.68M | 701.25K | 139.57% | 194.74% |
| Q2 2021 | -0.54 | -0.60 | 10.57% | 30.77% | 2.19M | 438.294K | 399.66% | 284.21% |
| Q1 2021 | -0.02 | -0.68 | 97.07% | 97.44% | 29.31M | 527.595K | 5,455.40% | 4,867.80% |
| Q4 2020 | -0.62 | -0.69 | 10.02% | - | 980K | 1.148M | -14.63% | - |
| Q3 2020 | -0.62 | -0.82 | 24.42% | - | 570K | 491.64K | 15.94% | - |
| Q2 2020 | -0.78 | -0.78 | -0.33% | - | 570K | 525.637K | 8.44% | - |
| Q1 2020 | -0.78 | -0.69 | -12.29% | - | 590K | 581.4K | 1.48% | - |
Notes
HOMOLOGY MEDICINES INC (FIXX) last reported earnings on 3/13/2024.
HOMOLOGY MEDICINES INC (FIXX) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, HOMOLOGY MEDICINES INC (FIXX) has beaten EPS estimates in 2 out of 4 releases.